Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation

Bernard Hausen, Peter Muller, Markus Bahra, Raj Ramsamooj, Charles W. Hewitt

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The pulmonary vasodilatory effects of prostacyclin (PGI2) were compared with inhaled nitric oxide (NO) for donor treatment in an acute double lung transplantation model in the rat. The PGI2 group (n=10) received 35 μg/kg PGI2 both intravenously and into the flush solution. The NO group (n=10) was ventilated before and during perfusion with nitric oxide for an expiratory NO concentration of 20 ppm. Both groups were compared with untreated controls (n=10). Following cold ischemia of 16 hr the donor lungs were implanted in syngeneic recipients via specially designed stents to the left pulmonary artery and vein. Separate graft ventilation permitted determination of compliance and resistance. During 120 min of reperfusion serial measurements of graft pulmonary vascular resistance (PVR) and alveolar arterial oxygen difference (AAD02) were obtained. Final graft assessment included weight gain and histological analysis. Data are listed as mean±SE. The type of donor pretreatment had a definite and negative impact on survival (NO: 106±6, controls: 116±4, PGI2:120±0 min; P<0.02) and overall graft function. During reperfusion the compliance was significantly reduced in NO (23±4) in comparison with controls (34±3) and PGI2 (50±4 ml/cmH2O; P<0.01). The PVR was 785±238 in NO, 240±60 in controls and 181±71 mmHg/ml/min in PGI2 (P<0.02). The AaD02 was compromised in NO (486±44) compared with controls (396±53) and PGI2 (108±34 mmHg; P<0.02). The weight increase at the end of reperfusion amounted to 101±17% in NO, 98±13% in controls, and 69±7% in PGI2 (P<0.05). Histological analysis showed significantly more interstitial edema in the NO group. In conclusion, PGI2 administration significantly improves global lung function while the inhalation of nitric oxide before and during donor perfusion has a detrimental effect on the quality of graft preservation.

Original languageEnglish (US)
Pages (from-to)1714-1719
Number of pages6
JournalTransplantation
Volume62
Issue number12
DOIs
StatePublished - Dec 27 1996
Externally publishedYes

Fingerprint

Lung Transplantation
Epoprostenol
Nitric Oxide
Transplants
Reperfusion
Vascular Resistance
Lung
Compliance
Perfusion
Cold Ischemia
Nitric Oxide Donors
Pulmonary Veins
Inhalation
Pulmonary Artery
Weight Gain
Stents
Ventilation
Edema
Oxygen
Weights and Measures

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation. / Hausen, Bernard; Muller, Peter; Bahra, Markus; Ramsamooj, Raj; Hewitt, Charles W.

In: Transplantation, Vol. 62, No. 12, 27.12.1996, p. 1714-1719.

Research output: Contribution to journalArticle

Hausen, Bernard ; Muller, Peter ; Bahra, Markus ; Ramsamooj, Raj ; Hewitt, Charles W. / Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation. In: Transplantation. 1996 ; Vol. 62, No. 12. pp. 1714-1719.
@article{c960fe210f0642b1a535dd8448a38350,
title = "Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation",
abstract = "The pulmonary vasodilatory effects of prostacyclin (PGI2) were compared with inhaled nitric oxide (NO) for donor treatment in an acute double lung transplantation model in the rat. The PGI2 group (n=10) received 35 μg/kg PGI2 both intravenously and into the flush solution. The NO group (n=10) was ventilated before and during perfusion with nitric oxide for an expiratory NO concentration of 20 ppm. Both groups were compared with untreated controls (n=10). Following cold ischemia of 16 hr the donor lungs were implanted in syngeneic recipients via specially designed stents to the left pulmonary artery and vein. Separate graft ventilation permitted determination of compliance and resistance. During 120 min of reperfusion serial measurements of graft pulmonary vascular resistance (PVR) and alveolar arterial oxygen difference (AAD02) were obtained. Final graft assessment included weight gain and histological analysis. Data are listed as mean±SE. The type of donor pretreatment had a definite and negative impact on survival (NO: 106±6, controls: 116±4, PGI2:120±0 min; P<0.02) and overall graft function. During reperfusion the compliance was significantly reduced in NO (23±4) in comparison with controls (34±3) and PGI2 (50±4 ml/cmH2O; P<0.01). The PVR was 785±238 in NO, 240±60 in controls and 181±71 mmHg/ml/min in PGI2 (P<0.02). The AaD02 was compromised in NO (486±44) compared with controls (396±53) and PGI2 (108±34 mmHg; P<0.02). The weight increase at the end of reperfusion amounted to 101±17{\%} in NO, 98±13{\%} in controls, and 69±7{\%} in PGI2 (P<0.05). Histological analysis showed significantly more interstitial edema in the NO group. In conclusion, PGI2 administration significantly improves global lung function while the inhalation of nitric oxide before and during donor perfusion has a detrimental effect on the quality of graft preservation.",
author = "Bernard Hausen and Peter Muller and Markus Bahra and Raj Ramsamooj and Hewitt, {Charles W.}",
year = "1996",
month = "12",
day = "27",
doi = "10.1097/00007890-199612270-00003",
language = "English (US)",
volume = "62",
pages = "1714--1719",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Donor pretreatment with intravenous prostacyclin versus inhaled nitric oxide in experimental lung transplantation

AU - Hausen, Bernard

AU - Muller, Peter

AU - Bahra, Markus

AU - Ramsamooj, Raj

AU - Hewitt, Charles W.

PY - 1996/12/27

Y1 - 1996/12/27

N2 - The pulmonary vasodilatory effects of prostacyclin (PGI2) were compared with inhaled nitric oxide (NO) for donor treatment in an acute double lung transplantation model in the rat. The PGI2 group (n=10) received 35 μg/kg PGI2 both intravenously and into the flush solution. The NO group (n=10) was ventilated before and during perfusion with nitric oxide for an expiratory NO concentration of 20 ppm. Both groups were compared with untreated controls (n=10). Following cold ischemia of 16 hr the donor lungs were implanted in syngeneic recipients via specially designed stents to the left pulmonary artery and vein. Separate graft ventilation permitted determination of compliance and resistance. During 120 min of reperfusion serial measurements of graft pulmonary vascular resistance (PVR) and alveolar arterial oxygen difference (AAD02) were obtained. Final graft assessment included weight gain and histological analysis. Data are listed as mean±SE. The type of donor pretreatment had a definite and negative impact on survival (NO: 106±6, controls: 116±4, PGI2:120±0 min; P<0.02) and overall graft function. During reperfusion the compliance was significantly reduced in NO (23±4) in comparison with controls (34±3) and PGI2 (50±4 ml/cmH2O; P<0.01). The PVR was 785±238 in NO, 240±60 in controls and 181±71 mmHg/ml/min in PGI2 (P<0.02). The AaD02 was compromised in NO (486±44) compared with controls (396±53) and PGI2 (108±34 mmHg; P<0.02). The weight increase at the end of reperfusion amounted to 101±17% in NO, 98±13% in controls, and 69±7% in PGI2 (P<0.05). Histological analysis showed significantly more interstitial edema in the NO group. In conclusion, PGI2 administration significantly improves global lung function while the inhalation of nitric oxide before and during donor perfusion has a detrimental effect on the quality of graft preservation.

AB - The pulmonary vasodilatory effects of prostacyclin (PGI2) were compared with inhaled nitric oxide (NO) for donor treatment in an acute double lung transplantation model in the rat. The PGI2 group (n=10) received 35 μg/kg PGI2 both intravenously and into the flush solution. The NO group (n=10) was ventilated before and during perfusion with nitric oxide for an expiratory NO concentration of 20 ppm. Both groups were compared with untreated controls (n=10). Following cold ischemia of 16 hr the donor lungs were implanted in syngeneic recipients via specially designed stents to the left pulmonary artery and vein. Separate graft ventilation permitted determination of compliance and resistance. During 120 min of reperfusion serial measurements of graft pulmonary vascular resistance (PVR) and alveolar arterial oxygen difference (AAD02) were obtained. Final graft assessment included weight gain and histological analysis. Data are listed as mean±SE. The type of donor pretreatment had a definite and negative impact on survival (NO: 106±6, controls: 116±4, PGI2:120±0 min; P<0.02) and overall graft function. During reperfusion the compliance was significantly reduced in NO (23±4) in comparison with controls (34±3) and PGI2 (50±4 ml/cmH2O; P<0.01). The PVR was 785±238 in NO, 240±60 in controls and 181±71 mmHg/ml/min in PGI2 (P<0.02). The AaD02 was compromised in NO (486±44) compared with controls (396±53) and PGI2 (108±34 mmHg; P<0.02). The weight increase at the end of reperfusion amounted to 101±17% in NO, 98±13% in controls, and 69±7% in PGI2 (P<0.05). Histological analysis showed significantly more interstitial edema in the NO group. In conclusion, PGI2 administration significantly improves global lung function while the inhalation of nitric oxide before and during donor perfusion has a detrimental effect on the quality of graft preservation.

UR - http://www.scopus.com/inward/record.url?scp=0030471494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030471494&partnerID=8YFLogxK

U2 - 10.1097/00007890-199612270-00003

DO - 10.1097/00007890-199612270-00003

M3 - Article

C2 - 8990349

AN - SCOPUS:0030471494

VL - 62

SP - 1714

EP - 1719

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 12

ER -